Jonathan Tosh BA (Leicester), MSc (LSE)

Research Fellow

HEDS, ScHARR
The University of Sheffield
Regent Court
30 Regent Street
Sheffield
S1 4DA
UK

Office: 2013

Tel: (+44) (0)114 222 0830
Fax: (+44) (0)114 272 4095

E-mail: j.tosh@sheffield.ac.uk

Biography

I joined ScHARR in November 2007, after completing a BA in Economics at the University Of Leicester and an MSc in International Health Policy (Health Economics) at the London School of Economics. For my MSc, I undertook a placement at the National Institute of Health and Clinical Excellence (NICE).

During my time at ScHARR I have worked on several economic modelling projects, mainly for chronic conditions. I was the health economist for the NICE Clinical Guideline for Rheumatoid Arthritis, and for the NICE Technology Appraisal Evidence Review Group for golimumab. I am a member of the NICE Decision Support Unit and ScHARR Technology Assessment Group, and through my role as a Health Economist for the Yorkshire and Humber Research Design Service (RDS-YH) I have an interest in undertaking economic evaluations alongside clinical trials.

Research interests

My research interests are:

• Health economics
• Decision analytic modelling in chronic conditions

Teaching interests

My teaching interests are:

• MSc Health Economics and Decision Modelling – HAR673 Dissertation (Module Lead)
• MSc Health Economics and Decision Modelling- HAR668 Introduction to Health Economics
• MBChB- Study Design and Critical Analysis

Professional activities

• Member of the NICE Decision Support Unit
• Member of the ScHARR Technology Assessment Group- ScHARR-TAG.
• Health Economic adviser for the NIHR Research Design Service in Yorkshire and the Humber (RDS-YH)

Current projects

• I am an NIHR Doctoral Research Fellow (2012-2014). For my PhD I am looking to develop a framework for the economic evaluation of sequential therapies for chronic conditions. I will undertake a case-study in rheumatoid arthritis. 

Key publications

• Tosh, J., Brazier, J., Evans, P., & Longworth, L. (2012, January). A review of generic preference-based measures of health-related quality of life in visual disorders. Value in Health, 15(1), 118-127. doi:10.1016/j.jval.2011.08.002
• Tosh, J., Brennan, A., Wailoo, A., & Bansback, N. (2011, September). The Sheffield rheumatoid arthritis health economic model. Rheumatology (Oxford), 50 Suppl 4, iv26-iv31. doi:10.1093/rheumatology/ker243
• Tosh, J, C. Wailoo, A,J., Scott, D. L., & Deighton, C, M. (2011). Cost-Effectiveness of Combination Nonbiologic Disease-Modifying Antirheumatic Drug Strategies in Patients with Early Rheumatoid Arthiritis. The Journal of Rheumatology. doi:10.3899/jrheum.101327
• Tosh, J, C., Longworth, L. J., & George, E. (2011). Utility values in National Institute for Health and Clinical Excellence (NICE) Technology Appraisals. Value in health, 14, 102-109. doi:10.1016/j.jval.2010.10.015
• Longworth L., Sculpher MJ, Bojke L, Tosh J,C . Bridging the gap between methods research and the needs of policy makers: A review of the research priorities of the National Institute for Health and Clinical Excellence. International Journal of Technology Assessment in Health Care. Firstview. 1-8. doi:10.1017/S0266462311000043
• Deighton C, O'Mahony R, Tosh J, Turner C, Rudolf M. Practice Guidelines Management of rheumatoid arthritis: summary of NICE guidance. British Medical Journal, 2009;338:b702. Full text here.
• National Collaborating Centre for Chronic Conditions (2009). Rheumatoid Arthritis: the management of rheumatoid arthritis in adults. Clinical Guideline 79. National Institute for Health and Clinical Excellence. (Download full guidance appendices for full economic analysis here.)